ADC Therapeutics Company
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Healthcare
Headquarters:
Lausanne, Vaud, Switzerland
Founded Date:
2011-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
7
Total Funding:
496392274
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-05-17
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership